Home›Stock Screener›Gujarat Themis Biosyn›Financial Statements

Gujarat Themis Biosyn Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Gujarat Themis Biosyn (GUJTHEM) reported revenue ₹45 Cr, net profit ₹11 Cr and EPS ₹1.00, with a net profit margin of 24.4% and ROE of 3.8%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Gujarat Themis Biosyn share price today.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 24.44% 2026 data
EBITDA Margin 44.44% 2026 data
Operating Margin 44.00% 2026 data
Return on Assets 2.19% 2026 data
Return on Equity 3.82% 2026 data

Balance Sheet Ratios

Current Ratio 0.65 2026 data
Equity Ratio 57.26% 2026 data
Asset Turnover 0.09 2026 data

GUJTHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

GUJTHEM YoY (Jun 2025 vs Mar 2026) — revenue +25.0%, net profit +22.2%, EBITDA +42.9%, expenses +13.6%.

Revenue Growth
+25.0%
Year-over-Year
Net Profit Growth
+22.2%
Year-over-Year
EBITDA Growth
+42.9%
Year-over-Year
Expense Growth
+13.6%
Year-over-Year
Assets Growth
+67.1%
Year-over-Year
Equity Growth
+16.1%
Year-over-Year
Operating Cash Flow Growth
-46.2%
Year-over-Year
Investing Cash Flow Growth
-53.6%
Year-over-Year
Financing Cash Flow Growth
+342.3%
Year-over-Year

GUJTHEM Income Statement — Revenue, EBITDA & Net Profit

Gujarat Themis Biosyn revenue ₹45 Cr, EBITDA ₹20 Cr, net profit ₹11 Cr, EPS ₹1.00 (2026) — net profit margin 24.4%. Compare with GUJTHEM stock valuation models to assess whether the stock is under or overvalued.

Periods ₹ Crores
Particulars Mar 2026 Jun 2026 Jun 2025
Revenue 45 44 36
Expenses 25 23 22
EBITDA 20 21 14
Operating Profit Margin % 44.00% 47.00% 39.00%
Depreciation 4 4 2
Interest 2 2 0
Profit Before Tax 14 15 12
Tax 3 4 3
Net Profit 11 11 9
Earnings Per Share (₹) 1.00 1.02 0.83

GUJTHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

GUJTHEM total assets ₹503 Cr, total equity ₹288 Cr, total liabilities ₹ Cr (2026) — ROE 3.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 503 301 221 166 123 88 64 33 21 21 15 15
Current Assets 89 52 48 62 78 63 29 8 8 8 3 4
Fixed Assets 289 41 38 33 19 19 17 15 11 11 9 10
Capital Work in Progress 121 184 91 21 13 2 0 1 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 93 76 92 113 90 67 47 17 10 11 5 5
LIABILITIES
Total Liabilities
Current Liabilities 137 32 4 2 2 3 5 1 1 1 2 6
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 288 248 201 149 103 70 42 19 12 8 4 -1
Share Capital 11 11 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 277 238 194 142 96 63 35 11 5 1 -3 -8

GUJTHEM Cash Flow Statement — Operating, Investing & Financing

Gujarat Themis Biosyn operating cash flow ₹49 Cr, investing ₹-172 Cr, financing ₹115 Cr, net cash flow ₹-9 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 49 91 64 40 40 11 1 1 6 3 4 3
Investing Activities -172 -112 -55 -20 -30 -2 -3 -6 -1 -3 -1 0
Financing Activities 115 26 -9 -13 -14 -5 2 5 -4 0 -3 -3
Net Cash Flow -9 5 0 6 -4 3 0 0 1 0 0 -1